Read some of our most frequently asked questions below. If you still have questions, please feel free to contact us directly.
Our Company is listed on the Toronto Stock Exchange (TSX) with the ticker CRH and on the New York Stock Exchange Market (NYSE MKT) with the ticker CRHM.
We only have one type of common shares.
Our shares cannot be purchased directly from us, they can be purchased through a broker or a trading service. We recommend that you contact a financial advisor, broker or trading service in your area to enquire about the logistics of investing in capital markets and purchasing our shares.
There are several public websites where investors can find historical trading data of our shares. Yahoo finance is one of the most popular ones.
Our fiscal year runs from January 1 to December 31.
Our registrar and transfer agent is Computershare Investor Services Inc. You can get in touch with Computershare by phone at 1-800-564-6253 (toll-free North America) or at (1) 514-982-7555 (international); by email at service@computershare.com; or by fax at 1-866-249-7775 (toll-free North America) or at (1) 416-263-9524 (international).
Please contact our registrar and transfer agent, Computershare, by phone at 1-800-564-6253 (toll-free North America) or at (1) 514-982-7555 (international); by email at service@computershare.com; or by fax at 1-866-249-7775 (toll-free North America) or at (1) 416-263-9524 (international).
If you use a financial advisor, broker or investment advisor and you opted to be an Objecting Beneficial Owner (OBO), we are not allowed to contact you directly and your shareholder correspondence is sent to you through an intermediary (your advisor, or broker), who has to retransmit all documents to you in due course. If that is the case, you can contact your advisor or broker and enquire about your documents.
Please contact our registrar and transfer agent, Computershare, by phone at 1-800-564-6253 (toll-free North America) or at (1) 514-982-7555 (international); by email at service@computershare.com; or by fax at 1-866-249-7775 (toll-free North America) or at (1) 416-263-9524 (international).
Our auditors are KPMG, LLP, Chartered Accountants. 777 Dunsmuir Street, Vancouver, BC, V7Y 1K3.
Our legal counsel is Blake, Cassels & Graydon LLP, Barristers and Solicitors, 595 Burrard Street, Suite 2600, Three Bentall Center, Vancouver, BC, V7X 1L3.
No, CRH Medical Corporation is not a PFIC. We recommend that investors consult a tax advisor to inform themselves of the possible tax implications of investing in our company.
We file our results with Canadian and US Securities regulators on a quarterly basis. Concurrently with the filing of our quarterly results, we issue a news release with highlights. Both our news releases and quarterly filings for the most recent three years can be found in the Investors section of our website at https://investorscrh.wpengine.com. Investors can also refer to the websites of the Canadian Securities Regulator (www.sedar.com) and US Securities Regulator (www.sec.gov/edgar.shtml) to obtain previously-disclosed documents. For details of our next results announcement, please visit the Investors/Events section of our website, where we post the announcement date and details of upcoming conference calls as soon as the information becomes public.
You can sign up to receive an email alert every time we publish an investor newsletter, issue a news release, or file public disclosure documents by visiting https://investorscrh.wpengine.com/press-releases and clicking on the “Sign Up to Receive Updates” button. You can unsubscribe at any point by emailing us at ir@crhmedcorp.com with the subject “Unsubscribe”.
We have not declared or paid any dividends on our outstanding common shares since our inception and we do not anticipate that we will do so in the foreseeable future. The declaration of dividends on our common shares is within the discretion of the Board of Directors.